Ultragenyx Pharmaceutical Inc. (RARE) Earnings Report - Forecasts and Surprise Ratio

Ultragenyx Pharmaceutical Inc.
RARE
(Nasdaq - US)
Closed
44.75
-2.89 (-6.08%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:0+0.00 (0.00%)
Open
47.50
High
47.67
Low
44.56

Quarterly Earnings History

RARE ratio: 40%

100%

RARE beat 14 of 35 last estimates

Date of next report: Feb 20, 2025

Estimate for Q4 24: $-1.33

Implied change from Q3 24: -5.00%

Implied change from Q4 23: -12.50%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 5, 2024	$-1.4 / $-1.45	$0.05 / 3.45%
Q2 24	Aug 1, 2024	$-1.52 / $-1.64	$0.12 / 7.32%
Q1 24	May 2, 2024	$-2.03 / $-1.72	$-0.31 / -18.02%
Q4 23	Feb 15, 2024	$-1.52 / $-1.65	$0.13 / 7.88%
Q3 23	Nov 2, 2023	$-2.23 / $-2.08	$-0.15 / -7.21%
Q2 23	Aug 3, 2023	$-2.25 / $-2.11	$-0.14 / -6.64%
Q1 23	May 4, 2023	$-2.33 / $-1.97	$-0.36 / -18.27%
Q4 22	Feb 16, 2023	$-2.16 / $-2.03	$-0.13 / -6.4%

Data Vendor: Xignite Logo